Transphorm Statistics
Total Valuation
Transphorm has a market cap or net worth of $308.55 million. The enterprise value is $304.55 million.
| Market Cap | 308.55M |
| Enterprise Value | 304.55M |
Important Dates
The next estimated earnings date is Tuesday, June 25, 2024, after market close.
| Earnings Date | Jun 25, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Transphorm has 63.36 million shares outstanding. The number of shares has increased by 9.60% in one year.
| Shares Outstanding | 63.36M |
| Shares Change (YoY) | +9.60% |
| Shares Change (QoQ) | +1.71% |
| Owned by Insiders (%) | 20.91% |
| Owned by Institutions (%) | 59.99% |
| Float | 25.66M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 16.54 |
| Forward PS | 8.54 |
| PB Ratio | 16.99 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 16.24 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.69, with a Debt / Equity ratio of 0.13.
| Current Ratio | 1.69 |
| Quick Ratio | 0.78 |
| Debt / Equity | 0.13 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -176.48 |
Financial Efficiency
Return on equity (ROE) is -197.70% and return on invested capital (ROIC) is -148.11%.
| Return on Equity (ROE) | -197.70% |
| Return on Assets (ROA) | -114.90% |
| Return on Capital (ROIC) | -148.11% |
| Revenue Per Employee | $146,523 |
| Profits Per Employee | -$325,781 |
| Employee Count | 128 |
| Asset Turnover | 0.52 |
| Inventory Turnover | 1.74 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +42.03% in the last 52 weeks. The beta is 0.44, so Transphorm's price volatility has been lower than the market average.
| Beta (1Y) | 0.44 |
| 52-Week Price Change | +42.03% |
| 50-Day Moving Average | 4.86 |
| 200-Day Moving Average | 3.63 |
| Relative Strength Index (RSI) | 59.55 |
| Average Volume (30 Days) | 215,486 |
Short Selling Information
The latest short interest is 815,013, so 1.29% of the outstanding shares have been sold short.
| Short Interest | 815,013 |
| Short Previous Month | 770,588 |
| Short % of Shares Out | 1.29% |
| Short % of Float | 3.18% |
| Short Ratio (days to cover) | 4.57 |
Income Statement
In the last 12 months, Transphorm had revenue of $18.76 million and -$41.70 million in losses. Loss per share was -$0.70.
| Revenue | 18.76M |
| Gross Profit | 3.51M |
| Operating Income | -30.54M |
| Pretax Income | -33.37M |
| Net Income | -41.70M |
| EBITDA | -31.48M |
| EBIT | -33.18M |
| Loss Per Share | -$0.70 |
Balance Sheet
The company has $7.95 million in cash and $2.37 million in debt, giving a net cash position of $5.58 million or $0.09 per share.
| Cash & Cash Equivalents | 7.95M |
| Total Debt | 2.37M |
| Net Cash | 5.58M |
| Net Cash Per Share | $0.09 |
| Equity / Book Value | 18.25M |
| Book Value Per Share | 0.29 |
| Working Capital | 8.54M |
Cash Flow
In the last 12 months, operating cash flow was -$22.29 million and capital expenditures -$1.88 million, giving a free cash flow of -$24.16 million.
| Operating Cash Flow | -22.29M |
| Capital Expenditures | -1.88M |
| Free Cash Flow | -24.16M |
| FCF Per Share | -$0.39 |
Margins
Gross margin is 18.73%, with operating and profit margins of -162.84% and -222.34%.
| Gross Margin | 18.73% |
| Operating Margin | -162.84% |
| Pretax Margin | -177.91% |
| Profit Margin | -222.34% |
| EBITDA Margin | -167.85% |
| EBIT Margin | -176.91% |
| FCF Margin | -128.84% |
Dividends & Yields
Transphorm does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -9.60% |
| Shareholder Yield | -9.60% |
| Earnings Yield | -13.45% |
| FCF Yield | -7.79% |
Analyst Forecast
The average price target for Transphorm is $3.50, which is -28.13% lower than the current price. The consensus rating is "Hold".
| Price Target | $3.50 |
| Price Target Difference | -28.13% |
| Analyst Consensus | Hold |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Transphorm has an Altman Z-Score of 0.07 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.07 |
| Piotroski F-Score | 4 |